HIGHLIGHTS
SUMMARY
Although the main focus regarding the ongoing coronavirus disease 2019 (COVID-19) pandemic has been the acute clinical manifestations of the disease, at this point, it is clear that understanding the sequelae of the disease is of equal, if not of utmost importance. Indeed, the novel term "post-COVID-19 syndrome" or "long-COVID" has been introduced for those individuals in whom COVID-19 can cause symptoms that last weeks or months 2 of 16 after the infection has resolved. Indeed, the authors found that the polymorphisms in GSTP1, GSTM3, GSTO1 and GSTO2 genes . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.